Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

60.43 +2.21 (+3.80%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
40 41 Next >
2 Stock-Split Stocks to Buy Without Hesitation in 2023
These companies have rock-solid businesses that can enrich investors over the long term. 
Via The Motley Fool
Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System
From DexCom, Inc.
Via Business Wire
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These companies should be able to carry their momentum well beyond this year. 
Via The Motley Fool
Costco Wholesale, Micron Technology And This Healthcare Stock Insiders Are Selling
The Nasdaq jumped by around 190 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Procter & Gamble's Prices, China's Population, and More
Plus, Dexcom CEO Kevin Sayer shares some insight on continuous glucose monitors. 
Via The Motley Fool
1 Top Growth Stock That Could Beat the Market In 2023 and Beyond
This company offers products that are essential to the well-being of its customers. 
Via The Motley Fool
Analyst Expectations for DexCom's Future
 
Via Benzinga
Is Abbott Laboratories a Good Dividend Stock to Buy Now?
At least four Wall Street banks recently raised their price targets for the healthcare giant. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
 
Via Benzinga
Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
10 Analysts Have This to Say About DexCom
 
Via Benzinga
2 No-Brainer Growth Stocks to Buy Right Now
Don't overlook these growth plays. 
Via The Motley Fool
Insulet Has Potential To Gain More Than Analysts Are Forecasting
Even as it pulled back with the broader market Tuesday, insulin pump maker Insulet found support along its 50-day line and remained in possible buy range. 
Via MarketBeat
The Top 7 “Millionaire-Maker” Long-Term Stocks for 2023
These companies have a track record of rewarding shareholders who own their stock over the long-term, providing gains of 1,000% or more. 
Via InvestorPlace
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
Sharp Tesla price cuts and some notable earnings were in focus. 
Via Investor's Business Daily
2 Best Stocks to Buy in January and Hold Forever
The new year is here, and with it, more opportunities to invest in wonderful companies. 
Via The Motley Fool
Want $1 Million in Retirement? Invest $300,000 in These 3 Stocks and Wait a Decade
Don't let your retirement planning fall by the wayside in the current market. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook
From DexCom, Inc.
Via Business Wire
Dexcom Appoints Teri Lawver as Chief Commercial Officer
From DexCom, Inc.
Via Business Wire
Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference
From DexCom, Inc.
Via Business Wire
Have $2,000 to Invest? 2 Top Stocks That Could Go Parabolic
Stocks with long-term growth potential abound even in the current market. 
Via The Motley Fool
2 Growth Stocks to Invest $1,500 in Before the End of 2022
Opportunities are abundant right now, even if share prices are down. 
Via The Motley Fool
The Best Stocks to Invest $5,000 in Right Now
Consistently investing your cash in both up and down markets can make you richer in the long run. 
Via The Motley Fool
1 Passive Income Stock to Buy Today, and 1 to Avoid for Now
Rising interest rates don't affect all passive income stocks equally. 
Via The Motley Fool
2 Breakout Growth Stocks to Buy for the Long Haul
These growing businesses are just starting to see the beginning of their long-term potential. 
Via The Motley Fool
Can FDA Approval Bolster DexCom, Inc.?
Dexcom is relying on the interest and sales of its new continuous glucose monitor--which recently received FDA approval--to boost revenue (and stock value). 
Via MarketBeat
Kaival Brands ($KAVL) and KMS gear up for anticipated revenue growth by hiring former Swisher International VP of Sales
Via AB Newswire
Topics Economy
Stock Market Rally Falls On Recession Fears; Tesla Plunges On China News: Weekly Review
The stock market rally suffered significant weekly losses as recession fears mounted. Tesla stock dived on China demand concerns. 
Via Investor's Business Daily
Have $1,000? 2 Smart Stocks to Buy in a Nasdaq Bear Market
A down market doesn't mean you should hit pause on adding new stocks to your portfolio. 
Via The Motley Fool
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
40 41 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.